EXO-CD24

May 10, 2021

A new coronavirus treatment being developed in Israel's Tel Aviv’s Ichilov Medical Center has successfully completed phase one trials and appears to have helped numerous moderate-to-serious cases of COVID-19 quickly recover from the disease.

About:

  • Hailing the treatment as a huge breakthrough, the hospital has said that the EXO-CD24 substance had been administered to 30 patients whose conditions were moderate or worse.

  • It added that all 30 recovered with 29 of them getting well within just three to five days.

  • The medicine is reported to fight the cytokine storm, which is a potentially lethal immune overreaction to the coronavirus infection that is believed to be responsible for much of the deaths associated with the disease.